C
COGT
Cogent Biosciences Inc
31.43
+0.02+0.06%Pre Market: 32.00 +0.57 +1.81%08:08 09/25 EDT
OPEN/PREV CLOSE31.17/30.87
TODAY RANGE29.70-31.17
VOL2.38M
MARKET CAP5.27B
52 WEEK RANGE13.78-43.73
AVG VOL (3M)1.94M
% TURNOVER1.18%
TURNOVER--
P/E (TTM)-14.1857
% RANGE4.76%
EPS(TTM)-2.1416
P/E(FORWARD)-13.4866
P/B9.79
BVPS3.103
DIVIDEND--
P/S15.80
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP5.17B
SHARES OUTSTANDING173.52M
NEXT EARNINGS11/02-11/06
FREE FLOAT170.32M
LOT SIZE1
EX-DATE11/09/2020
News
Press Releases
Financial Reports
Profile
TipRanks·10h ago
Guggenheim Remains a Buy on Cogent Biosciences (COGT)
Simply Wall St·09/26 00:32
Should FDA Filing Acceptance Require Action From Cogent Biosciences (COGT) Investors?
Simply Wall St·09/24 06:24
3 Reasons Cogent Biosciences (COGT) Valuation Looks Pricey Following FDA NDA Acceptance
Simply Wall St·09/18 05:31
Should FDA Filing Acceptance Require Action From Cogent Biosciences Stock Investors?
TipRanks·09/15 12:50
Analysts’ Top Healthcare Picks: GeoVax Labs (GOVX), Cogent Biosciences (COGT)
Seeking Alpha·09/15 12:28
Cogent Bio granted third FDA review for lead asset
TipRanks·09/15 12:10
Cogent Biosciences reports FDA acceptance of bezuclastinib new drug application
TipRanks·09/09 11:05
Cogent Biosciences added to Analyst Focus List at JPMorgan
TipRanks·09/02 22:14
Cogent Biosciences Secures Long-Term Bezuclastinib Supply Deal
Seeking Alpha·08/27 12:24
Cogent Biosciences: 3 NDAs Create A Time-To-Market Moat
Simply Wall St·08/24 15:25
What Cogent Biosciences (COGT)'s Widening Net Losses Mean For Shareholders
Seeking Alpha·08/23 09:52
Prelude Therapeutics: A Prognosis After Year-Long Rally
Seeking Alpha·08/22 21:57
SA Asks: What are the most promising oncology companies right now?
Same Industry
Name/Symbol
Change%
Price